| dbo:abstract |
Lasinavir (INN, previously known as BMS-234475 and CGP-61755) is an experimental peptidomimetic protease inhibitor researched by Novartis and Bristol-Myers Squibb as a treatment for HIV infection. It was originally discovered by Novartis at Basel (Switzerland).Its investigation was terminated after Phase I on October 09, 2002. (en) |
| dbo:iupacName |
tert-Butyl (3S,4S,6R,9S)-13-benzyl-12-hydroxy-6,9-dioxo-7-(propan-2-yl)-10-[(2,3,4-trimethoxyphenyl)methyl]-2-oxa-5,8,14-triazapentadecan-15-oate (en) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Lasinavir.svg?width=300 |
| dbo:wikiPageID |
48651056 (xsd:integer) |
| dbo:wikiPageLength |
3048 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1109268906 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbc:HIV_protease_inhibitors dbr:Basel dbc:Abandoned_drugs dbc:Carbamates dbc:Secondary_alcohols dbr:Protease_inhibitor_(pharmacology) dbr:Bristol-Myers_Squibb dbc:Carboxamides dbr:Novartis dbc:Tert-butyl_compounds dbr:HIV/AIDS dbr:International_Nonproprietary_Name dbr:Phases_of_clinical_research dbr:Peptidomimetic |
| dbp:imagefile |
Lasinavir.svg (en) |
| dbp:imagesize |
200 (xsd:integer) |
| dbp:pin |
tert-Butyl -13-benzyl-12-hydroxy-6,9-dioxo-7--10-[methyl]-2-oxa-5,8,14-triazapentadecan-15-oate (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:wikiPageUsesTemplate |
dbt:Chembox dbt:Chembox_Hazards dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:HIVpharm dbt:Antiinfective-drug-stub |
| dct:subject |
dbc:HIV_protease_inhibitors dbc:Abandoned_drugs dbc:Carbamates dbc:Secondary_alcohols dbc:Carboxamides dbc:Tert-butyl_compounds |
| gold:hypernym |
dbr:Inhibitor |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 dbo:ChemicalCompound dbo:Drug |
| rdfs:comment |
Lasinavir (INN, previously known as BMS-234475 and CGP-61755) is an experimental peptidomimetic protease inhibitor researched by Novartis and Bristol-Myers Squibb as a treatment for HIV infection. It was originally discovered by Novartis at Basel (Switzerland).Its investigation was terminated after Phase I on October 09, 2002. (en) |
| rdfs:label |
Lasinavir (en) |
| owl:sameAs |
yago-res:Lasinavir wikidata:Lasinavir dbpedia-vi:Lasinavir https://global.dbpedia.org/id/2MEB8 |
| prov:wasDerivedFrom |
wikipedia-en:Lasinavir?oldid=1109268906&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Lasinavir.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Lasinavir |
| is dbo:wikiPageWikiLink of |
dbr:List_of_drugs:_La |
| is foaf:primaryTopic of |
wikipedia-en:Lasinavir |
